GlassScriptPhysician profile
Simone Delecia West
NPI 1982047734
$2,919.13
in general payments reported to CMS, 2019-2025
34 companies · $293 in 2025
The $293 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $449 · 2021: $839 · 2022: $656 · 2023: $247 · 2024: $114 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $653.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $534.54 | 2019-2023 | Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $285.40 | 2019-2023 | Aptima, Affirm Prone Biopsy System |
| Exeltis, USA INC. | $244.93 | 2020-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $193.99 | 2019-2023 | |
| Therapeuticsmd, INC. | $187.55 | 2019-2022 | |
| Coopersurgical, INC. | $126.14 | 2020-2024 | Paragard T 380a, Paragard T 380a |
| Organon LLC | $117.75 | 2022-2023 | Nexplanon |
| Mylan Pharmaceuticals INC. | $116.68 | 2019-2022 | |
| Gynesonics, INC. | $109.90 | 2022 | |
| Smith+Nephew, INC. | $101.81 | 2022-2025 | Pico 14 |
| Scynexis, INC. | $99.13 | 2022 | |
| Agile Therapeutics, INC. | $91.63 | 2021 | |
| Myovant Sciences INC. | $87.74 | 2021-2022 | |
| Astellas Pharma US INC | $71.92 | 2025 | Veozah |
| Lupin INC. | $63.57 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $57.13 | 2024-2025 | |
| Mayne Pharma Commercial LLC | $47.64 | 2021-2022 | |
| Millicent US INC | $43.82 | 2025 | Intrarosa, Femring, Femlyv |
| Sumitomo Pharma America, INC. | $36.47 | 2023-2024 | Myfembree |
| Shield Therapeutics INC | $35.07 | 2022-2024 | |
| Avion Pharmaceuticals | $25.13 | 2021 | |
| Dexcom, INC. | $24.89 | 2025 | Dexcom G6 Transmitter |
| Vertical Pharmaceuticals, LLC | $23.27 | 2019 | |
| Mission Pharmacal Company | $22.95 | 2021 | |
| Daiichi Sankyo INC. | $22.87 | 2019 | |
| Solventum Corporation | $21.62 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Baxter Healthcare | $19.30 | 2025 | Perclot |
| Meditrina | $17.31 | 2021 | |
| Allergan, INC. | $16.32 | 2020 | |
| Amgen INC. | $16.04 | 2025 | Prolia, Evenity |
| Aspira Women'S Health INC | $14.98 | 2019 | |
| Zyla Life Sciences, INC. | $14.89 | 2020 | |
| Innovation Technologies INC | $13.55 | 2025 | Irrisept |
| Amag Pharmaceuticals, INC. | $13.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simone West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.